19 May 2025 Date | | - Cons. EPS | 0 EPS |
14 Nov 2024 Date | | - Cons. EPS | - EPS |
22 Aug 2024 Date | | - Cons. EPS | - EPS |
19 Aug 2024 Date | | - Cons. EPS | - EPS |
16 Aug 2024 Date | | - Cons. EPS | - EPS |
19 May 2025 Date | | - Cons. EPS | 0 EPS |
14 Nov 2024 Date | | - Cons. EPS | - EPS |
22 Aug 2024 Date | | - Cons. EPS | - EPS |
19 Aug 2024 Date | | - Cons. EPS | - EPS |
16 Aug 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Dr. Timothy Richard Scott Ph.D. CEO | OTC PINK Exchange | 58463A105 Cusip |
US Country | 91 Employees | - Last Dividend | 28 Apr 2009 Last Split | - IPO Date |
Medical Marijuana, Inc. operates as an investment holding company within the cannabinoid-based nutraceutical industry. Since its incorporation in 2005 and based out of San Diego, California, the company has centered its efforts on the development, sale, and distribution of a variety of hemp oil products, which include naturally occurring cannabinoids like cannabidiol (CBD). Furthermore, it focuses on leveraging the medicinal properties of cannabis/cannabinoid through innovative delivery methods like chewing gum for the treatment of pain and various medical conditions. Medical Marijuana, Inc. actively engages in scientific research geared towards discovering new therapeutic agents aimed at reducing oxidative stress, and acting as immuno-modulators as well as neuroprotectants. The company's operations span from the production of dietary supplements and skin care products to the development of prescription-based hemp oil, falling under the brands Kannaway and HempMeds. Additionally, it involves itself in proprietary activities related to testing, genetics, labeling, packaging, tracking, and establishing production and standardization methods for the medicinal cannabinoid industry, aiming to set a benchmark in quality and safety.
Medical Marijuana, Inc. deals in hemp oil products that are rich in naturally occurring cannabinoids, including CBD. These products are designed for people seeking the health benefits of cannabinoids without the psychoactive effects of THC.
Utilizing innovative delivery systems for medicinal cannabis, the company has developed a line of chewing gum-based products aimed at treating pain and other medical disorders, offering a discreet and convenient option for consumption.
Medical Marijuana, Inc. also commercializes products high in CBD but low in THC, targeting individuals looking for the therapeutic benefits of cannabidiol without experiencing psychoactive effects.
The company dedicates resources towards the research and development of new therapeutic agents, focusing on reducing oxidative stress, and acting as immuno-modulators and neuroprotectants, in a bid to advance the medical applications of cannabinoids.
Under the Kannaway and HempMeds brands, a diverse range of products, including dietary supplements, skin care products, and prescription-based hemp oil, are offered. These are aimed at leveraging the health benefits of hemp and CBD for overall well-being.
The company stands out by offering proprietary services in testing, genetics, labeling, packaging, tracking, and production, aiming to ensure the highest standards of quality and safety for medicinal cannabinoid products.
RSHO oil is positioned as a treatment option for a variety of illnesses and conditions, encapsulating the therapeutic potentials of hemp oil.
Recognizing the growing demand for quality pet products, Medical Marijuana, Inc. has introduced a line of plant-based, non-GMO pet products focusing on health, wellness, play, and environmentally-friendly supplies for pets.